{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:30:21Z","timestamp":1787164221191,"version":"build-2736575974"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ypmed.2020.106293","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T21:03:35Z","timestamp":1602882215000},"page":"106293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Surveillance systems for monitoring cervical cancer elimination efforts: Focus on HPV infection, cervical dysplasia, cervical screening and treatment"],"prefix":"10.1016","volume":"144","author":[{"given":"Julia M.L.","family":"Brotherton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosette","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary M.","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Elfstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Saville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kaldor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy A.","family":"Machalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2020.106293_bb0005","doi-asserted-by":"crossref","first-page":"k4823","DOI":"10.1136\/bmj.k4823","article-title":"Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.ypmed.2020.106293_bb0010","series-title":"Cervical screening in Australia 2019. Cancer Series No. 123. Cat. No. CAN 124","author":"Australian Institute of Health and Welfare","year":"2019"},{"issue":"5","key":"10.1016\/j.ypmed.2020.106293_bb0015","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ijc.31409","article-title":"Impacts of human papillomavirus vaccination for different populations: a modeling study","volume":"143","author":"Baussano","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2020.106293_bb0020","doi-asserted-by":"crossref","DOI":"10.7326\/M20-2849","article-title":"Prevalence of Human Papillomavirus and Estimation of Human Papillomavirus Vaccine Effectiveness in Thimphu, Bhutan, in 2011\u20132012 and 2018","author":"Baussano","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ypmed.2020.106293_bb0025","doi-asserted-by":"crossref","DOI":"10.3201\/eid2701.191364","article-title":"Impact of human papillomavirus vaccination in Rwanda and Bhutan: Evidence from urine-based impact monitoring surveys","author":"Baussano","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.ypmed.2020.106293_bb0030","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/cncr.30507","article-title":"Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States","volume":"123","author":"Beavis","year":"2017","journal-title":"Cancer."},{"issue":"6","key":"10.1016\/j.ypmed.2020.106293_bb0035","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jamaoncol.2016.3609","article-title":"Population-based incidence rates of cervical intraepithelial Neoplasia in the human papillomavirus vaccine era","volume":"3","author":"Benard","year":"2017","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.ypmed.2020.106293_bb0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens--part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol."},{"issue":"9783","key":"10.1016\/j.ypmed.2020.106293_bb0045","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(11)60551-5","article-title":"Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study","volume":"377","author":"Brotherton","year":"2011","journal-title":"Lancet."},{"issue":"3","key":"10.1016\/j.ypmed.2020.106293_bb0050","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.vaccine.2018.11.075","article-title":"Age-specific HPV prevalence among 116,052 women in Australia\u2019s renewed cervical screening program: a new tool for monitoring vaccine impact","volume":"37","author":"Brotherton","year":"2019","journal-title":"Vaccine."},{"key":"10.1016\/j.ypmed.2020.106293_bb0055","doi-asserted-by":"crossref","first-page":"100177","DOI":"10.1016\/j.pvr.2019.100177","article-title":"Is one dose of human papillomavirus vaccine as effective as three?: a national cohort analysis","volume":"8","author":"Brotherton","year":"2019","journal-title":"Papillomavirus Res."},{"key":"10.1016\/j.ypmed.2020.106293_bb0060","doi-asserted-by":"crossref","first-page":"100192","DOI":"10.1016\/j.pvr.2019.100192","article-title":"IPVS policy statement. Equity in cervical cancer prevention: for all and not just for some","volume":"9","author":"Brotherton","year":"2020","journal-title":"Papillomavirus Res."},{"issue":"12","key":"10.1016\/j.ypmed.2020.106293_bb0065","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.ypmed.2020.106293_bb0070","doi-asserted-by":"crossref","first-page":"383","DOI":"10.5694\/mja2.50506","article-title":"The value of data linkage depends on the quality of the data: incorporating Medicare data alters cervical screening analysis findings","volume":"212","author":"Budd","year":"2020","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.ypmed.2020.106293_bb0075","series-title":"Optimal care pathway for women with cervical cancer","author":"Cancer Australia","year":"2020"},{"issue":"10224","key":"10.1016\/j.ypmed.2020.106293_bb0080","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(20)30157-4","article-title":"Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Canfell","year":"2020","journal-title":"Lancet."},{"issue":"1","key":"10.1016\/j.ypmed.2020.106293_bb0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2303.2011.00948.x","article-title":"Review of cytology and histopathology as part of the NHS cervical screening Programme audit of invasive cervical cancers","volume":"23","author":"Castanon","year":"2012","journal-title":"Cytopathology."},{"key":"10.1016\/j.ypmed.2020.106293_bb0090","first-page":"1","article-title":"Updated guidelines for evaluating public health surveillance systems","volume":"50","author":"Centre for Disease Control and Prevention","year":"2001","journal-title":"MMWR Recomm Rep."},{"issue":"11","key":"10.1016\/j.ypmed.2020.106293_bb0095","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S1473-3099(15)00055-9","article-title":"Human papillomavirus in young women with chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study","volume":"15","author":"Chow","year":"2015","journal-title":"Lancet Infect. Dis."},{"issue":"27","key":"10.1016\/j.ypmed.2020.106293_bb0100","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1200\/JCO.2016.68.3789","article-title":"Management and care of women with invasive cervical cancer: ASCO resource-stratified clinical practice guideline","volume":"34","author":"Chuang","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"9490","key":"10.1016\/j.ypmed.2020.106293_bb0105","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","article-title":"Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis","volume":"366","author":"Clifford","year":"2005","journal-title":"Lancet."},{"key":"10.1016\/j.ypmed.2020.106293_bb0110","author":"Communicable Diseases Network Australia (CDNA)"},{"key":"10.1016\/j.ypmed.2020.106293_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2020.07.037","article-title":"Reduction in HPV16\/18 positive high-grade cervical lesions in a population offered catch-up vaccination","author":"Cornall","year":"2020","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ypmed.2020.106293_bb0120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/PDM.0b013e31827f3f7e","article-title":"Effect of HPV assay choice on perceived prevalence in a population-based sample","volume":"22","author":"Cuschieri","year":"2013","journal-title":"Diagn. Mol. Pathol."},{"issue":"11","key":"10.1016\/j.ypmed.2020.106293_bb0125","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.ypmed.2020.106293_bb0130","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/infdis\/jiy067","article-title":"High effectiveness of the bivalent human papillomavirus (HPV) vaccine against incident and persistent HPV infections up to 6 years after vaccination in young Dutch women","volume":"217","author":"Donken","year":"2018","journal-title":"J. Infect. Dis."},{"issue":"10197","key":"10.1016\/j.ypmed.2020.106293_bb0135","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"issue":"29","key":"10.1016\/j.ypmed.2020.106293_bb0140","first-page":"625","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years--United States, 2013","volume":"63","author":"Elam-Evans","year":"2014","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"12","key":"10.1016\/j.ypmed.2020.106293_bb0145","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/infdis\/jiy432","article-title":"Substantial decline in prevalence of vaccine-type and nonvaccine-type human papillomavirus (HPV) in vaccinated and unvaccinated girls 5 years after implementing HPV vaccine in Norway","volume":"218","author":"Feiring","year":"2018","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.ypmed.2020.106293_bb0150","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.2105\/AJPH.2016.303472","article-title":"Ecological association of human papillomavirus vaccination with cervical dysplasia prevalence in the United States, 2007-2014","volume":"106","author":"Flagg","year":"2016","journal-title":"Am. J. Public Health"},{"issue":"11","key":"10.1016\/j.ypmed.2020.106293_bb0155","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/ijc.22241","article-title":"Variations in the age-specific curves of human papillomavirus prevalence in women worldwide","volume":"119","author":"Franceschi","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.ypmed.2020.106293_bb0160","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/ijc.30092","article-title":"Urine testing to monitor the impact of HPV vaccination in Bhutan and Rwanda","volume":"139","author":"Franceschi","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"32 Pt A","key":"10.1016\/j.ypmed.2020.106293_bb0165","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1016\/j.vaccine.2018.02.002","article-title":"Options for design of real-world impact studies of single-dose vaccine schedules","volume":"36","author":"Franceschi","year":"2018","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.ypmed.2020.106293_bb0170","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/cid\/ciy707","article-title":"Trends in high-grade cervical lesions and cervical cancer screening in 5 states, 2008-2015","volume":"68","author":"Gargano","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ypmed.2020.106293_bb0175","unstructured":"Gargano J, Meites E, Watson M, Unger U, Markowitz L. Chapter 5: Manual for the Surveillance of Vaccine-Preventable Diseases. Centers for Disease Control and Prevention Department of Health and Human Services."},{"key":"10.1016\/j.ypmed.2020.106293_bb0180","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1741-7015-11-227","article-title":"Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study","volume":"11","author":"Gertig","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.ypmed.2020.106293_bb2000","doi-asserted-by":"crossref","first-page":"105833","DOI":"10.1016\/j.ypmed.2019.105833","article-title":"Burden of disease attributable to second-hand smoke exposure: A systematic review","volume":"129","author":"Carreras","year":"2019","journal-title":"Prev Med."},{"issue":"8","key":"10.1016\/j.ypmed.2020.106293_bb0185","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/aogs.13608","article-title":"Hysterectomy-corrected cervical cancer mortality rates in Denmark during 2002-2015: a registry-based cohort study","volume":"98","author":"Hammer","year":"2019","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"4","key":"10.1016\/j.ypmed.2020.106293_bb0190","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/infdis\/jir341","article-title":"Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003-2006","volume":"204","author":"Hariri","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"50","key":"10.1016\/j.ypmed.2020.106293_bb0195","doi-asserted-by":"crossref","first-page":"7682","DOI":"10.1016\/j.vaccine.2018.10.075","article-title":"Impact of human papillomavirus vaccination on racial\/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26year old females in the U.S","volume":"36","author":"Hirth","year":"2018","journal-title":"Vaccine."},{"issue":"4","key":"10.1016\/j.ypmed.2020.106293_bb0200","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/aje\/kwz253","article-title":"Effectiveness of 1, 2, and 3 doses of human papillomavirus vaccine against high-grade cervical lesions positive for human papillomavirus 16 or 18","volume":"189","author":"Johnson Jones","year":"2020","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.ypmed.2020.106293_bb0205","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1158\/1055-9965.EPI-14-0775","article-title":"Human papillomavirus genotype-specific prevalence across the continuum of cervical neoplasia and cancer","volume":"24","author":"Joste","year":"2015","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"10","key":"10.1016\/j.ypmed.2020.106293_bb0210","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024477","article-title":"Opportunistic HPV vaccination at age 16-23 and cervical screening attendance in Sweden: a national register-based cohort study","volume":"8","author":"Kreusch","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.ypmed.2020.106293_bb0215","doi-asserted-by":"crossref","first-page":"l1207","DOI":"10.1136\/bmj.l1207","article-title":"Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study","volume":"365","author":"Lei","year":"2019","journal-title":"BMJ."},{"issue":"1","key":"10.1016\/j.ypmed.2020.106293_bb0220","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41416-020-0850-6","article-title":"Impact of HPV vaccination on cervical screening performance: a population-based cohort study","volume":"123","author":"Lei","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.ypmed.2020.106293_bb0225","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/infdis\/jiy075","article-title":"Very low prevalence of vaccine human papillomavirus types among 18- to 35-year old Australian women 9 years following implementation of vaccination","volume":"217","author":"Machalek","year":"2018","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ypmed.2020.106293_bb0230","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5694\/mja2.50223","article-title":"Routine cervical screening by primary HPV testing: early findings in the renewed National Cervical Screening Program","volume":"211","author":"Machalek","year":"2019","journal-title":"Med. J. Aust."},{"issue":"5","key":"10.1016\/j.ypmed.2020.106293_bb0235","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cmi.2019.09.006","article-title":"Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans","volume":"26","author":"Maver","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"issue":"29","key":"10.1016\/j.ypmed.2020.106293_bb0240","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1016\/j.vaccine.2018.05.104","article-title":"Decline in prevalence of human papillomavirus infection following vaccination among Australian indigenous women, a population at higher risk of cervical cancer: the VIP-I study","volume":"36","author":"McGregor","year":"2018","journal-title":"Vaccine."},{"issue":"6","key":"10.1016\/j.ypmed.2020.106293_bb0245","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/infdis\/jiy249","article-title":"The impact of the national HPV vaccination program in England using the bivalent HPV vaccine: surveillance of type-specific HPV in Young females, 2010-2016","volume":"218","author":"Mesher","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ypmed.2020.106293_bb0250","series-title":"NCCN guidelines, version 4.2019 cervical cancer","author":"National Comprehensive Clinical Network (NCCN)","year":"2019"},{"key":"10.1016\/j.ypmed.2020.106293_bb0255","series-title":"Cervixcancerprevention: Nationellt v\u00e5rdprogram och konsekvenser av inf\u00f6rande av Socialstyrelsens rekommendationer g\u00e4llande screening juni 2015","author":"National Working Group for Cervical Cancer Prevention","year":"2017"},{"issue":"8","key":"10.1016\/j.ypmed.2020.106293_bb0260","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1158\/1055-9965.EPI-13-0272","article-title":"Declining rates of high-grade cervical lesions in young women in Connecticut, 2008-2011","volume":"22","author":"Niccolai","year":"2013","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"6","key":"10.1016\/j.ypmed.2020.106293_bb0265","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/cid\/cix455","article-title":"Declines in human papillomavirus (HPV)-associated high-grade cervical lesions after introduction of HPV vaccines in Connecticut, United States, 2008-2015","volume":"65","author":"Niccolai","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.ypmed.2020.106293_bb0270","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/infdis\/jix244","article-title":"Prevalence of human papillomavirus among females after vaccine introduction-National Health and nutrition examination survey, United States, 2003-2014","volume":"216","author":"Oliver","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ypmed.2020.106293_bb0275","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jviromet.2018.11.008","article-title":"Human papillomavirus detection in urine: effect of a first-void urine collection device and timing of collection","volume":"264","author":"Pattyn","year":"2019","journal-title":"J. Virol. Methods"},{"issue":"9","key":"10.1016\/j.ypmed.2020.106293_bb0280","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.cmi.2020.03.033","article-title":"Commercially available molecular tests for human papillomaviruses: a global overview","volume":"26","author":"Poljak","year":"2020","journal-title":"Clin Microbiol Infect."},{"issue":"2","key":"10.1016\/j.ypmed.2020.106293_bb0285","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jnci\/djz074","article-title":"Efficacy, safety, and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine: an interim analysis of a randomized clinical trial","volume":"112","author":"Qiao","year":"2020","journal-title":"J. Natl. Cancer Inst."},{"issue":"13","key":"10.1016\/j.ypmed.2020.106293_bb0290","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/cncr.28548","article-title":"Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009","volume":"120","author":"Rositch","year":"2014","journal-title":"Cancer."},{"issue":"5","key":"10.1016\/j.ypmed.2020.106293_bb0295","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.pathol.2020.04.002","article-title":"Performance measures for Australian laboratories reporting cervical cytology 2009-2017: the impact of the national HPV vaccination program","volume":"52","author":"Ross","year":"2020","journal-title":"Pathology."},{"issue":"7295","key":"10.1016\/j.ypmed.2020.106293_bb0300","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1136\/bmj.322.7295.1179","article-title":"Routine audit is an ethical requirement of screening","volume":"322","author":"Sasieni","year":"2001","journal-title":"BMJ."},{"issue":"8","key":"10.1016\/j.ypmed.2020.106293_bb0305","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/bjc.1996.196","article-title":"Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group","volume":"73","author":"Sasieni","year":"1996","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ypmed.2020.106293_bb0310","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.bjc.6600974","article-title":"Benefit of cervical screening at different ages: evidence from the UK audit of screening histories","volume":"89","author":"Sasieni","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.ypmed.2020.106293_bb0315","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ijc.24410","article-title":"Screening and adenocarcinoma of the cervix","volume":"125","author":"Sasieni","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.ypmed.2020.106293_bb0320","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1158\/1055-9965.EPI-12-1406","article-title":"Human papillomavirus infection and the multistage carcinogenesis of cervical cancer","volume":"22","author":"Schiffman","year":"2013","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"5","key":"10.1016\/j.ypmed.2020.106293_bb0325","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.vaccine.2019.11.019","article-title":"Monitoring human papillomavirus prevalence among young Australian women undergoing routine chlamydia screening","volume":"38","author":"Shilling","year":"2020","journal-title":"Vaccine."},{"issue":"4","key":"10.1016\/j.ypmed.2020.106293_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(20)30060-7","article-title":"Trends in sexual activity and demand for and use of modern contraceptive methods in 74 countries: a retrospective analysis of nationally representative surveys","volume":"8","author":"Slaymaker","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.ypmed.2020.106293_bb0335","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1756-0500-7-109","article-title":"Testing previous model predictions against new data on human papillomavirus vaccination program outcomes","volume":"7","author":"Smith","year":"2014","journal-title":"BMC Res Notes."},{"issue":"12","key":"10.1016\/j.ypmed.2020.106293_bb0340","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1158\/1055-9965.EPI-14-0687","article-title":"Change in population prevalences of human papillomavirus after initiation of vaccination: the high-throughput HPV monitoring study","volume":"23","author":"Soderlund-Strand","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"12","key":"10.1016\/j.ypmed.2020.106293_bb0345","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1002\/ijc.32050","article-title":"Is the positive predictive value of high-grade cytology in predicting high-grade cervical disease falling due to HPV vaccination?","volume":"144","author":"Sultana","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ypmed.2020.106293_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.07.042","article-title":"Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study","volume":"216","author":"Sundstrom","year":"2017","journal-title":"Am J Obstet Gynecol."},{"issue":"11","key":"10.1016\/j.ypmed.2020.106293_bb0355","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/infdis\/jis590","article-title":"Fall in human papillomavirus prevalence following a national vaccination program","volume":"206","author":"Tabrizi","year":"2012","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.ypmed.2020.106293_bb0360","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S1473-3099(14)70841-2","article-title":"Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study","volume":"14","author":"Tabrizi","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ypmed.2020.106293_bb0365","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pvr.2017.01.001","article-title":"Human papillomavirus (HPV) in young women in Britain: population-based evidence of the effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types","volume":"3","author":"Tanton","year":"2017","journal-title":"Papillomavirus Res."},{"key":"10.1016\/j.ypmed.2020.106293_bb0370","first-page":"djz222","article-title":"Efficacy of the AS04-adjuvanted HPV-16\/18 vaccine: Pooled analysis of the Costa Rica Vaccine and PATRICIA randomized controlled trials","author":"Tota","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ypmed.2020.106293_bb0375","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/1471-2334-14-408","article-title":"Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme","volume":"14","author":"Tshomo","year":"2014","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.ypmed.2020.106293_bb0380","doi-asserted-by":"crossref","first-page":"14","DOI":"10.15585\/mmwr.mm6801a4","article-title":"Establishing baseline cervical Cancer screening coverage - India, 2015-2016","volume":"68","author":"Van Dyne","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"33","key":"10.1016\/j.ypmed.2020.106293_bb0385","doi-asserted-by":"crossref","first-page":"718","DOI":"10.15585\/mmwr.mm6833a2","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2018","volume":"68","author":"Walker","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"10","key":"10.1016\/j.ypmed.2020.106293_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002414","article-title":"Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden","volume":"14","author":"Wang","year":"2017","journal-title":"PLoS Med."},{"issue":"8","key":"10.1016\/j.ypmed.2020.106293_bb0395","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1080\/0284186X.2020.1764095","article-title":"Increase of cervical cancer incidence in Sweden in relation to screening history: population cohort study","volume":"59","author":"Wang","year":"2020","journal-title":"Acta Oncol."},{"issue":"1","key":"10.1016\/j.ypmed.2020.106293_bb0400","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ijc.27608","article-title":"A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination","volume":"132","author":"Wheeler","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2020.106293_bb0405","series-title":"Human Papillomavirus Vaccines: WHO Position Paper. No 19","first-page":"241","volume":"92","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.ypmed.2020.106293_bb0410","series-title":"Draft Global Strategy towards eliminating cervical cancer as a public health problem","author":"World Health Organization","year":"2020"},{"issue":"3","key":"10.1016\/j.ypmed.2020.106293_bb0415","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-001351","article-title":"Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis","volume":"4","author":"Yeh","year":"2019","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.ypmed.2020.106293_bb0420","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/1471-2407-13-296","article-title":"Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study)","volume":"13","author":"Young","year":"2013","journal-title":"BMC Cancer"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743520303170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743520303170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:08:22Z","timestamp":1758794902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743520303170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":85,"alternative-id":["S0091743520303170"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2020.106293","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surveillance systems for monitoring cervical cancer elimination efforts: Focus on HPV infection, cervical dysplasia, cervical screening and treatment","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2020.106293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106293"}}